Analyzing the effect of annonacin on diverse breast cancer cell lines as a potential therapeutic agent for triple negative breast cancer

被引：0
|
作者：
Hernandez-Torres, Jennifer
Guzman, Kelly Argueta
机构：
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2024年 / 33卷 / 09期
关键词：
D O I：
10.1158/1538-7755.DISP24-C026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C026
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
    Xu, Na
    Li, Baohong
    Liu, Yong
    Yang, Cui
    Tang, Siqi
    Cho, William C.
    Huang, Zunnan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [12] Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer
    Li, Chia-Jung
    Tzeng, Yen-Dun Tony
    Chiu, Yi-Han
    Lin, Hung-Yu
    Hou, Ming-Feng
    Chu, Pei-Yi
    CANCERS, 2021, 13 (12)
  • [13] Prenylated Stilbenoids as Potential Therapeutic Agents for Triple Negative Breast Cancer
    Mohammad-Hosseinpour, Sepideh
    Ho, Linh-Chi
    Long, Cecily
    Medina-Bolivar, Fabricio
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2020, 56 (01) : S21 - S21
  • [14] Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models
    Rupp, Tristan
    Pelouin, Oceane
    Genest, Laurie
    Legrand, Christophe
    Froget, Guillaume
    Castagne, Vincent
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
  • [15] Raloxifene potentiates the effect of gefitinib in triple-negative breast cancer cell lines
    Taurin, Sebastien
    Rosengren, Rhonda J.
    MEDICAL ONCOLOGY, 2022, 40 (01)
  • [16] Raloxifene potentiates the effect of gefitinib in triple-negative breast cancer cell lines
    Sebastien Taurin
    Rhonda J. Rosengren
    Medical Oncology, 40
  • [17] Assessment of Notch Signaling Pathway Components as Biomarkers for Triple Negative Breast Cancer: Comparison of Triple Negative Breast Cancer Cell Lines and Human Breast Cancer Samples.
    Zlobin, A.
    Olsauskas-Kuprys, R.
    Hodge, S.
    O'Toole, M.
    Ersahin, C.
    Osipo, C.
    CANCER RESEARCH, 2012, 72
  • [18] Wortmannin as Targeted Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer
    Li, Jian
    Liu, Fei
    Liu, Yang
    Du, Jia-Jun
    Liu, Qi
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (01) : 95 - 99
  • [19] Synergy of Ixabepilone and Dasatinib in Triple Negative Breast Cancer Cell Lines
    Ismail-Khan, R. R.
    Marichion, D. C.
    Cubitt, C. L.
    Lancaster, J. M.
    CANCER RESEARCH, 2010, 70
  • [20] Exploring the antiproliferative potential of KHS101 on triple negative breast cancer cell lines
    Gurung, Reshma
    Yirsaw, Alehegne W.
    Khodary, Muhammad G.
    Samuel, Temesgen
    Sandey, Maninder
    Yates, Clayton C.
    Bedi, Deepa
    CANCER RESEARCH, 2024, 84 (06)
12345